Selected publications from OnkPat
OnkPat publications with Impact factor 8 and higher:
2019
Prognostic implications of PD-L1 expression in breast cancer: systematic review and meta-analysis of immunohistochemistry and pooled analysis of transcriptomic data.
Matikas A, Zerdes I, Lövrot J, Richard F, Sotiriou C, Bergh J, et al
Clin. Cancer Res. 2019 Jun;():
Breast cancer quantitative proteome and proteogenomic landscape.
Johansson HJ, Socciarelli F, Vacanti NM, Haugen MH, Zhu Y, Siavelis I, et al
Nat Commun 2019 04;10(1):1600
Proteogenomics and Hi-C reveal transcriptional dysregulation in high hyperdiploid childhood acute lymphoblastic leukemia.
Yang M, Vesterlund M, Siavelis I, Moura-Castro LH, Castor A, Fioretos T, et al
Nat Commun 2019 04;10(1):1519
Human Fis1 regulates mitochondrial dynamics through inhibition of the fusion machinery.
Yu R, Jin SB, Lendahl U, Nistér M, Zhao J
EMBO J. 2019 Apr;38(8):
Impact of Epithelial-Stromal Interactions on Peritumoral Fibroblasts in Ductal Carcinoma in Situ.
Strell C, Paulsson J, Jin SB, Tobin NP, Mezheyeuski A, Roswall P, et al
J. Natl. Cancer Inst. 2019 Feb;():
A Novel ACKR2-Dependent Role of Fibroblast-Derived CXCL14 in Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer.
Sjöberg E, Meyrath M, Milde L, Herrera M, Lövrot J, Hägerstrand D, et al
Clin. Cancer Res. 2019 Mar;():
Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials.
Lancet 2019 Apr;393(10179):1440-1452
Utility of Gonadotropin-Releasing Hormone Agonists for Fertility Preservation: Lack of Biologic Basis and the Need to Prioritize Proven Methods.
Turan V, Bedoschi G, Rodriguez-Wallberg K, Sonmezer M, Pacheco FS, Oktem O, et al
J. Clin. Oncol. 2019 Jan;37(1):84-86
Dose tailoring of adjuvant chemotherapy for breast cancer based on hematologic toxicities: further results from the prospective PANTHER study with focus on obese patients.
Matikas A, Foukakis T, Moebus V, Greil R, Bengtsson NO, Steger GG, et al
Ann. Oncol. 2019 Jan;30(1):109-114
Integrated Molecular Analysis of Undifferentiated Uterine Sarcomas Reveals Clinically Relevant Molecular Subtypes.
Binzer-Panchal A, Hardell E, Viklund B, Ghaderi M, Bosse T, Nucci MR, et al
Clin. Cancer Res. 2019 Apr;25(7):2155-2165
SubCellBarCode: Proteome-wide Mapping of Protein Localization and Relocalization.
Orre LM, Vesterlund M, Pan Y, Arslan T, Zhu Y, Fernandez Woodbridge A, et al
Mol. Cell 2019 Jan;73(1):166-182.e7
Identifying purine nucleoside phosphorylase as the target of quinine using cellular thermal shift assay.
Dziekan JM, Yu H, Chen D, Dai L, Wirjanata G, Larsson A, et al
Sci Transl Med 2019 Jan;11(473):
Ultrasensitive Immunoprofiling of Plasma Extracellular Vesicles Identifies Syndecan-1 as a Potential Tool for Minimally Invasive Diagnosis of Glioma.
Indira Chandran V, Welinder C, Månsson AS, Offer S, Freyhult E, Pernemalm M, et al
Clin. Cancer Res. 2019 May;25(10):3115-3127
Updated results from the phase 3 HELIOS study of ibrutinib, bendamustine, and rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma.
Fraser G, Cramer P, Demirkan F, Silva RS, Grosicki S, Pristupa A, et al
Leukemia 2019 04;33(4):969-980
A network of chaperones prevents and detects failures in membrane protein lipid bilayer integration.
Coelho JPL, Stahl M, Bloemeke N, Meighen-Berger K, Alvira CP, Zhang ZR, et al
Nat Commun 2019 02;10(1):672
Ribosome biogenesis during cell cycle arrest fuels EMT in development and disease.
Prakash V, Carson BB, Feenstra JM, Dass RA, Sekyrova P, Hoshino A, et al
Nat Commun 2019 05;10(1):2110
TP53 Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer.
De Laere B, Oeyen S, Mayrhofer M, Whitington T, van Dam PJ, Van Oyen P, et al
Clin. Cancer Res. 2019 Mar;25(6):1766-1773
Hepatic posttranscriptional network comprised of CCR4-NOT deadenylase and FGF21 maintains systemic metabolic homeostasis.
Morita M, Siddiqui N, Katsumura S, Rouya C, Larsson O, Nagashima T, et al
Proc. Natl. Acad. Sci. U.S.A. 2019 Apr;116(16):7973-7981
Fam83F induces p53 stabilisation and promotes its activity.
Salama M, Benitez-Riquelme D, Elabd S, Munoz L, Zhang P, Glanemann M, et al
Cell Death Differ. 2019 Oct;26(10):2125-2138
Immune cell constitution in bone marrow microenvironment predicts outcome in adult ALL.
Hohtari H, Brück O, Blom S, Turkki R, Sinisalo M, Kovanen PE, et al
Leukemia 2019 Jul;33(7):1570-1582
Phosphorylation of G3BP1-S149 does not influence stress granule assembly.
Panas MD, Kedersha N, Schulte T, Branca RM, Ivanov P, Anderson P
J. Cell Biol. 2019 Jul;218(7):2425-2432
EglN3 hydroxylase stabilizes BIM-EL linking VHL type 2C mutations to pheochromocytoma pathogenesis and chemotherapy resistance.
Li S, Rodriguez J, Li W, Bullova P, Fell SM, Surova O, et al
Proc. Natl. Acad. Sci. U.S.A. 2019 Aug;116(34):16997-17006
Anagrelide for Gastrointestinal Stromal Tumor.
Pulkka OP, Gebreyohannes YK, Wozniak A, Mpindi JP, Tynninen O, Icay K, et al
Clin. Cancer Res. 2019 Mar;25(5):1676-1687
Early-Stage NSCLC: Advances in Thoracic Oncology 2018.
Osarogiagbon RU, Veronesi G, Fang W, Ekman S, Suda K, Aerts JG, et al
J Thorac Oncol 2019 Jun;14(6):968-978
Generally applicable transcriptome-wide analysis of translation using anota2seq.
Oertlin C, Lorent J, Murie C, Furic L, Topisirovic I, Larsson O
Nucleic Acids Res. 2019 Jul;47(12):e70
The Case Against the European Medicines Agency's Change to the Label for Radium-223 for the Treatment of Metastatic Castration-resistant Prostate Cancer.
O'Sullivan JM, Heinrich D, James ND, Nilsson S, Ost P, Parker CC, et al
Eur. Urol. 2019 03;75(3):e51-e52
Multiplex Quantitative Analysis of Tumor-Infiltrating Lymphocytes and Immunotherapy Outcome in Metastatic Melanoma.
Wong PF, Wei W, Smithy JW, Acs B, Toki MI, Blenman KRM, et al
Clin. Cancer Res. 2019 Apr;25(8):2442-2449
Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL.
Xu-Monette ZY, Xiao M, Au Q, Padmanabhan R, Xu B, Hoe N, et al
Cancer Immunol Res 2019 Apr;7(4):644-657
Avoiding over- and undertreatment in patients with resected node-positive breast cancer with the use of gene expression signatures: are we there yet?
Matikas A, Foukakis T, Swain S, Bergh J
Ann. Oncol. 2019 Jul;30(7):1044-1050
Discontinuation of adjuvant hormone therapy among breast cancer patients not previously attending mammography screening.
He W, Eriksson L, Törnberg S, Strand F, Hall P, Czene K
BMC Med 2019 01;17(1):24
Monitoring structural modulation of redox-sensitive proteins in cells with MS-CETSA.
Sun W, Dai L, Yu H, Puspita B, Zhao T, Li F, et al
Redox Biol 2019 Jun;24():101168
MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort.
Pellegrini C, Botta F, Massi D, Martorelli C, Facchetti F, Gandini S, et al
Lancet Child Adolesc Health 2019 May;3(5):332-342
Lethal Poisoning of Cancer Cells by Respiratory Chain Inhibition plus Dimethyl α-Ketoglutarate.
Sica V, Bravo-San Pedro JM, Izzo V, Pol J, Pierredon S, Enot D, et al
Cell Rep 2019 Apr;27(3):820-834.e9
Implant Based Breast Reconstruction With Acellular Dermal Matrix: Safety Data From an Open-label, Multicenter, Randomized, Controlled Trial in the Setting of Breast Cancer Treatment.
Lohmander F, Lagergren J, Roy PG, Johansson H, Brandberg Y, Eriksen C, et al
Ann. Surg. 2019 May;269(5):836-841
Sperm count in Swedish clinical stage I testicular cancer patients following adjuvant treatment.
Weibring K, Nord C, Ståhl O, Eberhard J, Sandberg K, Johansson H, et al
Ann. Oncol. 2019 Apr;30(4):604-611
HER2: defining a Neu target in non-small-cell lung cancer.
Ekman S
Ann. Oncol. 2019 Mar;30(3):353-355
FGFR4 phosphorylates MST1 to confer breast cancer cells resistance to MST1/2-dependent apoptosis.
Turunen SP, von Nandelstadh P, Öhman T, Gucciardo E, Seashore-Ludlow B, Martins B, et al
Cell Death Differ. 2019 Mar;():
Distinct Cancer-Promoting Stromal Gene Expression Depending on Lung Function.
Sandri BJ, Masvidal L, Murie C, Bartish M, Avdulov S, Higgins L, et al
Am. J. Respir. Crit. Care Med. 2019 Aug;200(3):348-358
Making immunotherapy 'cold' tumours 'hot' by chemotherapy-induced mutations-a misconception.
Helleday T
Ann. Oncol. 2019 Mar;30(3):360-361
Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1-2 trial.
de Bono JS, Concin N, Hong DS, Thistlethwaite FC, Machiels JP, Arkenau HT, et al
Lancet Oncol. 2019 Mar;20(3):383-393
Amot and Yap1 regulate neuronal dendritic tree complexity and locomotor coordination in mice.
Rojek KO, Krzemień J, Doleżyczek H, Boguszewski PM, Kaczmarek L, Konopka W, et al
PLoS Biol. 2019 May;17(5):e3000253
Horizontal Cell Biology: Monitoring Global Changes of Protein Interaction States with the Proteome-Wide Cellular Thermal Shift Assay (CETSA).
Dai L, Prabhu N, Yu LY, Bacanu S, Ramos AD, Nordlund P
Annu. Rev. Biochem. 2019 Jun;88():383-408
Previous years
Selected publications from 2018 OnkPat